VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans

被引:91
|
作者
Limdi, Nita A. [1 ]
Beasley, T. Mark [2 ]
Crowley, Michael R. [3 ]
Goldstein, Joyce A. [4 ]
Rieder, Mark J. [5 ]
Flockhart, David A. [6 ]
Arnett, Donna K. [7 ]
Acton, Ronald T. [8 ]
Liu, Nianjun [2 ]
机构
[1] Univ Alabama, Dept Neurol, Birmingham, AL 35294 USA
[2] Univ Alabama, Dept Biostat, Sect Stat Genet, Birmingham, AL 35294 USA
[3] Univ Alabama, Dept Genet, Birmingham, AL 35294 USA
[4] NIEHS, Lab Pharmacol & Chem, Res Triangle Pk, NC USA
[5] Univ Washington, Dept Genome Sci, Washington, DC USA
[6] Indiana Univ, Sch Med, Div Clin Pharmacol, Bloomington, IN 47405 USA
[7] Univ Alabama, Dept Epidemiol, Birmingham, AL USA
[8] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA
关键词
African-Americans; cohort study; CYP2C9; European-Americans; pharmacogenetics; VKORC1; haplotypes; warfarin;
D O I
10.2217/14622416.9.10.1445
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Although the influence of VKORC1 and CYP2C9 polymorphisms on warfarin response has been studied, variability in dose explained by CYP2C9 and VKORC1 is lower among African-Americans compared with European-Americans. This has lead investigators to hypothesize that assessment of VKORC1 haplotypes may help capture a greater proportion of the variability in dose for this under-represented group. However, the inadequate representation of African-Americans and the assessment of a few VKORC1 polymorphisms have hindered this effort. Methods: To determine if VKORC1 haplotypes or haplotype groups explain a higher variability in warfarin dose, we comprehensively assessed VKORC1 polymorphisms in 273 African-Americans and 302 European-Americans. The influence of VKORC1 polymorphisms, race-specific haplotypes and haplotype groups on warfarin dose was evaluated in race-stratified multivariable analyses after accounting for CYP2C9 (*2, *3, *5, *6 and *11) and clinical covariates. Results: VKORC1 explained 18% (30% with CYP2C9) variability in warfarin dose among European-Americans and 5% (8% with CYP2C9) among African-Americans. Four common haplotypes in European-Americans and twelve in African-Americans were identified. In each race VKORC1 haplotypes emerged into two groups: low-dose (Group A) and high-dose (Group 13). African-Americans had a lower frequency of Group A haplotype (10.6%) compared with European-Americans (35%, p < 0.0001). The variability in dose explained by VKORC1 haplotype or haplotype groups was similar to that of a single informative polymorphism. Conclusions: Our findings support the use of CYP2C9, VKORC1 polymorphisms (rs9934438 or rs9923231) and clinical covariates to predict warfarin dose in both African- and European-Americans. A uniform set of common polymorphisms in CYP2C9 and VKORC1, and limited clinical covariates can be used to improve warfarin dose prediction for a racially diverse population.
引用
收藏
页码:1445 / 1458
页数:14
相关论文
共 50 条
  • [31] Circadian rhythm phase shifts and endogenous free-running circadian period differ between African-Americans and European-Americans
    Eastman, Charmane I.
    Suh, Christina
    Tomaka, Victoria A.
    Crowley, Stephanie J.
    [J]. SCIENTIFIC REPORTS, 2015, 5
  • [32] Circadian rhythm phase shifts and endogenous free-running circadian period differ between African-Americans and European-Americans
    Charmane I. Eastman
    Christina Suh
    Victoria A. Tomaka
    Stephanie J. Crowley
    [J]. Scientific Reports, 5
  • [33] NOCTURNAL BLOOD-PRESSURE (BP) IN TREATED HYPERTENSIVE AFRICAN-AMERICANS (AA) COMPARED TO TREATED HYPERTENSIVE EUROPEAN-AMERICANS (EA)
    HEBERT, LA
    AGARWAL, G
    REIF, M
    HIREMATH, L
    CARLTON, S
    NAHMAN, NS
    FALKENHAIN, ME
    LADSONWOFFORD, S
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 641 - 641
  • [34] Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans
    Luo, XG
    Kranzler, HR
    Zhao, HY
    Gelernter, J
    [J]. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2003, 120B (01) : 97 - 108
  • [35] Genetic polymorphism and prostate cancer aggressiveness: A case-only study of 1,536 GWAS and candidate SNPs in African-Americans and European-Americans
    Bensen, Jeannette T.
    Xu, Zongli
    Smith, Gary J.
    Mohler, James L.
    Fontham, Elizabeth T. H.
    Taylor, Jack A.
    [J]. PROSTATE, 2013, 73 (01): : 11 - 22
  • [36] Explaining the difference in lipoprotein(a) [Lp(a)] levels between European-Americans (EAs) and African-Americans (AAs) using a new genetic analysis.
    Chretien, JP
    Coresh, J
    Fink, NE
    Klag, MJ
    Marcovina, SM
    Giaculli, F
    Smith, MW
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 2001, 153 (11) : S68 - S68
  • [37] Frequency of Common VKORC1 Polymorphisms and Their Impact on Warfarin Dose Requirement in Pakistani Population
    Qayyum, Aisha
    Najmi, Muzammil Hasan
    Mansoor, Qaisar
    Irfan, Muhammad
    Naveed, Abdul Khaliq
    Hanif, Andleeb
    Kazmi, Ali Raza
    Ismail, Muhammad
    [J]. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2018, 24 (02) : 323 - 329
  • [38] The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
    Perera, M. A.
    Gamazon, E.
    Cavallari, L. H.
    Patel, S. R.
    Poindexter, S.
    Kittles, R. A.
    Nicolae, D.
    Cox, N. J.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (03) : 408 - 415
  • [39] Analysis of HLA-DPB1 polymorphisms in African-Americans with sarcoidosis
    Maliarik, MJ
    Chen, KM
    Major, ML
    Sheffer, RG
    Popovich, J
    Rybicki, BA
    Iannuzzi, MC
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (01) : 111 - 114
  • [40] Genome-Wide Association Study of Nicotine Dependence in American Populations: Identification of Novel Risk Loci in Both African-Americans and European-Americans
    Gelernter, Joel
    Kranzler, Henry R.
    Sherva, Richard
    Almasy, Laura
    Herman, Aryeh I.
    Koesterer, Ryan
    Zhao, Hongyu
    Farrer, Lindsay A.
    [J]. BIOLOGICAL PSYCHIATRY, 2015, 77 (05) : 493 - 503